TRZAX
Price
$53.75
Change
+$0.45 (+0.84%)
Updated
Jun 2 closing price
Net Assets
33.31B
VIVAX
Price
$83.19
Change
+$0.71 (+0.86%)
Updated
Jun 2 closing price
Net Assets
237.83B
Interact to see
Advertisement

TRZAX vs VIVAX

Header iconTRZAX vs VIVAX Comparison
Open Charts TRZAX vs VIVAXBanner chart's image
TRZAX vs VIVAX Comparison Chart in %
View a ticker or compare two or three
VS
TRZAX vs. VIVAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRZAX is a StrongBuy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 238B vs. TRZAX (33.3B). VIVAX pays higher dividends than TRZAX: VIVAX (1.76) vs TRZAX (1.42). TRZAX was incepted earlier than VIVAX: TRZAX (6 years) vs VIVAX (34 years). TRZAX (0.56) is less costly to investors than VIVAX (0.17). TRZAX is a more actively managed with annual turnover of: 59.50 vs. VIVAX (8.00). TRZAX (0) and VIVAX (0) have matching initial minimum investment requirements. VIVAX annual gain was more profitable for investors over the last year : 23.23 vs. TRZAX (16.55). VIVAX return over 5 years is better than : 50.69 vs. TRZAX (17.97).
TRZAXVIVAXTRZAX / VIVAX
Total Expense Ratio0.000.17-
Annual Report Gross Expense Ratio0.560.17329%
Fund Existence6 years34 years-
Gain YTD11.43610.667107%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets33.3B238B14%
Annual Yield % from dividends1.421.7681%
Returns for 1 year16.5523.2371%
Returns for 3 years44.4753.1684%
Returns for 5 years17.9750.6935%
Returns for 10 yearsN/A150.43-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SIBLX30.92N/A
N/A
Touchstone Balanced Y
SPSDX20.32N/A
N/A
Sterling Capital Behav Sm Cp Val Eq C
MEGMX22.28N/A
N/A
Matthews Emerging Markets Equity Inv
SMGIX42.74N/A
N/A
Columbia Contrarian Core Inst
BMSRX16.56N/A
N/A
MFS Blended Research Mid Cap Eq R1